| abstract |
(57) Abstract: Provided is a pharmaceutical composition for treating or preventing a tumor necrosis factor ("TNF")-mediated disease or a disease that is an interleukin-1 ("IL-1")-mediated disease. . A pharmaceutical composition for treating or preventing a tumor necrosis factor ("TNF") mediated disease or an interleukin-1 ("IL-1") mediated disease, comprising TN A pharmaceutical composition comprising an IL-1 receptor antagonist and a pharmaceutically acceptable carrier for simultaneous or sequential administration of an F inhibitor. |